John Cush/rheumnow.com
Jan 11, 2026, 06:59
John Cush: Subcutaneous Anifrolumab Effective in Lupus
John Cush, Executive Editor at RheumNow.com, shared a post on LinkedIn:
“Subcutaneous Anifrolumab Effective in Lupus
A new study published in Arthritis and Rheumatology demonstrates that subcutaneous administration of anifrolumab provides efficacy comparable to intravenous administration, offering a promising alternative for at-home care of patients living with moderate-to-severe SLE.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 4, 2026, 17:17Dan Annetts: The Fabulous CREATE Fertility Bristol Team This Week
-
Sep 4, 2026, 17:15Arsiak Vartenian: The Question I Wish Fertility Clinics Asked Women More…
-
Sep 4, 2026, 17:13Zeynab Kazemianpour: 2 Unusual Oocytes Observed Before ICSI
-
Sep 4, 2026, 17:11Saff Mitten: Do You Ever Worry Your Friends Are Getting Bored of Your Long IVF Journey?
-
Sep 4, 2026, 17:04David Pening: New Article on the Genetic Landscape of Acephalic Spermatozoa Syndrome
-
Sep 4, 2026, 16:55Blessed Obediran: The Science of Donor Conception Is Easy, The Harder Questions Are the Ethical Ones
-
Sep 4, 2026, 16:51Delighted to Welcome a Team of Colleagues from St. Gallen, Switzerland – Brussels IVF
-
Sep 4, 2026, 16:48Vikrant Bhatia: In Fertility Care, More Information Doesn’t Always Mean Better Decisions
-
Sep 4, 2026, 16:46Priyadatt Patel: Few Numbers Cause as Much Unnecessary Distress as AMH